Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial
R. Blay, Luis Flores, Kevin Kupzyk, Nancy Waltman, Joan M. Lappe, Lynn R. Mack, Laura D. Bilek
Topics & Concepts
MedicineOsteoporosisBone mineralQuantitative computed tomographyRandomized controlled trialMenopauseHip fractureBone densityPhysical therapyOsteopeniaInternal medicineBone health and osteoporosis researchParathyroid Disorders and TreatmentsBone and Joint Diseases